Several years ago, long-term strategic planning in health care would have taken into account large, national networks of providers and insurers, and integrated manufacturing/distribution companies that would control supply channels. Neither trend has played out, forcing planners to ask, how real is radical change?
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.